Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage.
about
Alternative expression of TCRζ related genes in patients with chronic myeloid leukemiaExpression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myelomaChallenges and future perspectives of T cell immunotherapy in cancerVariations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population.Upregulated TCRζ enhances interleukin-2 production in T-cells from patients with CML.NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy.Immunodeficiency and immunotherapy in multiple myeloma.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Can we change the disease biology of multiple myeloma?Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.A change in CD3γ, CD3δ, CD3ϵ, and CD3ζ gene expression in T-lymphocytes from benzene-exposed and benzene-poisoned workers.Assessment of immune function after short-term administration of recombinant human growth hormone in healthy young males.Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment.Long-term effects of idiotype vaccination on the specific T-cell response in peripheral blood and bone marrow of multiple myeloma patients.Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma.Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients.Infectious complications after chemotherapy and stem cell transplantation in multiple myeloma: implications of Fc gamma receptor and myeloperoxidase promoter polymorphisms.Chemotherapy-related infections in patients with multiple myeloma: associations with mannan-binding lectin genotypes.
P2860
Q21198862-00AD6CF8-CB76-4BA5-BD69-B867D464EF4AQ34278892-650EB7E7-5FA7-4D01-9303-4EE79533B0EBQ34369823-07004876-4190-403D-AD95-28D1C9675822Q35843507-B0D6D29A-7CE5-4C84-82C9-36E8D08C5B4CQ35854831-663E7021-F476-4729-A861-3EBBA217F6CBQ36350996-2DCA31F1-5C24-4A26-BECA-D2BDB489A160Q36608648-DA27AF01-2210-4823-B679-2D6BA78CC223Q36904977-4C19DE46-F1CA-436F-8A4A-BFB59DCBC552Q38014834-3B32BE46-8533-4BA0-9448-AF333B721C3FQ38062038-A3E59EB9-9F90-483E-AE6A-A4A31B3C13C8Q38729516-863B04D2-A42D-4B5D-A143-3178AF1F6416Q39832619-975748CE-19B0-4301-ADE3-85143F3BAF9FQ42722610-3A1C515C-BB11-4FA2-84A3-F74795D35641Q43428344-2F72F1E6-AD88-44F0-B102-06E6F0A3C2D7Q45861931-1CC03E60-0BD6-4405-B6DB-99B41A610686Q45871757-0C2E3E44-8956-415A-98DD-3FBBF98080D3Q46002196-82F9D995-CE98-4362-AF03-7AD109A6B1E3Q50714887-924E2079-BC7F-4ED1-B4E5-CE799CAF3FC6Q50853922-9AB2DB72-9B86-4B18-B543-161B6082D20EQ54534536-43B9886E-C6E7-428C-9BFA-B408BA034EC2Q54593179-65DD5FC2-5409-430C-A377-BEC44C270C98
P2860
Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Signalling molecules and cytok ...... malities with advancing stage.
@en
Signalling molecules and cytok ...... malities with advancing stage.
@nl
type
label
Signalling molecules and cytok ...... malities with advancing stage.
@en
Signalling molecules and cytok ...... malities with advancing stage.
@nl
prefLabel
Signalling molecules and cytok ...... malities with advancing stage.
@en
Signalling molecules and cytok ...... malities with advancing stage.
@nl
P2093
P2860
P1476
Signalling molecules and cytok ...... malities with advancing stage.
@en
P2093
Anders Osterborg
Eva D Rossmann
Fariba Mozaffari
Hodjattallah Rabbani
Håkan Mellstedt
Lotta Hansson
Shahryar Kiaii
P2860
P304
P356
10.1046/J.1365-2141.2003.04789.X
P407
P577
2004-02-01T00:00:00Z